Risk factors for neurological complications and their correlation with survival following pediatric liver transplantation

Pediatr Transplant. 2014 Mar;18(2):177-84. doi: 10.1111/petr.12218. Epub 2013 Dec 30.

Abstract

Despite the improved outcomes of LT, post-operative NCs remain a significant cause of morbidity and mortality. The aim of the study was to identify the incidence of and risk factors for NCs in children who underwent LT. The medical records of pediatric patients who underwent LT at Asan Medical Center Children's Hospital between January 1994 and December 2010 were retrospectively analyzed. The onset and types of NC and pretransplant variables associated with NC were evaluated. We identified 190 children (85 boys [44.7%], 105 girls [55.3%]) of mean age 4.1 ± 4.7 yr, who underwent LT. Forty-six NCs occurred in 41 (21.6%) patients after LT, the most common being seizures (n = 13, 28.3%) and encephalopathy (n = 10, 21.7%). Of the 46 NCs, 24 (52.2%) occurred within three months after LT. Multivariate analysis showed that primary liver disease, preoperative neurological problems, preoperatively higher serum creatinine concentration, and graft failure were significant risk factors for NCs. The survival rate was significantly lower for patients with NCs than for those without (p < 0.001). NCs after pediatric LTs were common and associated with a higher mortality rate in our study. Close monitoring and appropriate risk management may improve the long-term outcomes of pediatric patients who undergo LT.

Keywords: children; immunosuppressive treatment; liver transplantation; neurological complication.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Infant, Newborn
  • Liver Failure / complications
  • Liver Failure / mortality
  • Liver Failure / surgery*
  • Liver Transplantation*
  • Male
  • Multivariate Analysis
  • Nervous System Diseases / complications
  • Nervous System Diseases / etiology*
  • Retrospective Studies
  • Risk Factors
  • Seizures / complications
  • Seizures / etiology
  • Survival Rate
  • Treatment Outcome

Substances

  • Immunosuppressive Agents